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ABSTRACT
As the formation of ribonucleoprotein complexes is
a major mechanism of angiotensin II type 1 recep-
tor (AT1R) regulation, we sought to identify novel
AT1R mRNA binding proteins. By affinity purifica-
tion and mass spectroscopy, we identified TIA-1.
This interaction was confirmed by colocalization of
AT1R mRNA and TIA-1 by FISH and immunofluo-
rescence microscopy. In immunoprecipitates of en-
dogenous TIA- 1, reverse transcription-PCR ampli-
fied AT1R mRNA. TIA-1 has two binding sites within
AT1R 3′-UTR. The binding site proximal to the cod-
ing region is glyceraldehyde-3-phosphate dehydro-
genase (GAPDH)-dependent whereas the distal bind-
ing site is not. TIA-1 functions as a part of endoplas-
mic reticulum (ER) stress response leading to stress
granule (SG) formation and translational silencing.
We and others have shown that AT1R expression
is increased by ER stress-inducing factors. In un-
stressed cells, TIA-1 binds to AT1R mRNA and de-
creases AT1R protein expression. Fluorescence mi-
croscopy shows that ER stress induced by thapsi-
gargin leads to the transfer of TIA-1 to SGs. In FISH
analysis AT1R mRNA remains in the cytoplasm and
no longer colocalizes with TIA-1. Thus, release of
TIA-1-mediated suppression by ER stress increases
AT1R protein expression. In conclusion, AT1R mRNA
is regulated by TIA-1 in a ER stress-dependent man-
ner.
INTRODUCTION
Angiotensin II is central hormonal regulator of the function
and structure of cardiovascular system. It is among themost
powerful vasoconstrictors and inducers of aldosterone se-
cretion and it exerts these effects via the angiotensin II type
1 receptor (AT1R). Accordingly, the regulation ofAT1R ex-
pression is a critical mechanism that modulates the activ-
ity of renin-angiotensin system (RAS). Apart from hemo-
dynamic effects, angiotensin II (Ang II) induces extracellu-
lar matrix production, cellular hypertrophy and apoptosis
(1,2).
Through their influence on protein expression patterns,
RNA-binding proteins (RBPs) regulate the response of
AT1R to stress and hormones. Messenger RNA (mRNA)
levels do not directly translate into protein levels as mRNA
localization, half-life, and translation are regulated post-
transcriptionally by RBPs or small interfering RNAs.
Ang II forms a negative feedback loop by two post-
transcriptional mechanisms. First, Ang II increases AUF1
expression and its binding to AT1R mRNA. The binding
of AUF1 to mRNA results in its destabilization and de-
creased protein expression (3). Second, Ang II activates the
phosphorylation of calreticulin by cellular Src kinase. Phos-
phorylated calreticulin in turn increases the decay of AT1R
mRNA (4,5).
AT1R expression has been shown to be positively regu-
lated for example in hyperinsulinemia, hyperthyroidism and
during oxidative stress. Post-transcriptional regulation of
AT1R by insulin links hyperinsulinemia, a hallmark of type
2 diabetes, to hypertension. The post-transcriptional regu-
lation mediated by insulin results from HuR translocation
from nucleus to cytoplasm where it stabilizes AT1RmRNA
via 3′-untranslated region (3′-UTR) leading to increased re-
ceptor expression (6). Hyperthyroidism may lead to hyper-
tension, due to increased RAS activity. Thyroid hormone
has been shown to induce an increase in the poly-A tail
length of AT1R mRNA leading to increased AT1R expres-
sion (7). Reactive oxygen species (ROS) are keymediators of
signaling pathways that underlie vascular inflammation in
atherogenesis, starting from the initiation of fatty streak de-
velopment, through lesion progression, to ultimate plaque
rupture. In atherosclerotic lesions, AT1R is upregulated (8).
Oxidative stress results in a wide variety of coordinated
adaptive responses that result in increased AT1R expres-
sion. Oxidative stress by H2O2 dissociates GAPDH from
AT1RmRNA, leading to reduced translational suppression
by GAPDH, and thus increased AT1R protein expression
(9).
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Our previous studies, focused on the post-transcriptional
regulation of AT1R, have used affinity purification using
AT1R mRNA as bait to identify RBPs (6,9,10). In this
study, we started from an observation that TIA-1 interacts
with AT1RmRNAunder unstressed condition. TIA-1 is an
RBP that shuttles between cytoplasm and nucleus and func-
tions downstreamof the endoplasmic reticulum (ER) stress-
induced phosphorylation of eIF2 to promote recruitment
of mRNA into stress granules (SG) (11). TIA-1 binds to
AT1R mRNA in unstressed cells whereas ER stress disso-
ciates TIA-1 from AT1R mRNA and thus AT1R mRNA
avoids sequestration into SGs and translational suppres-
sion. Rather than being suppressed, AT1R expression is in-
creased under ER stress.
MATERIALS AND METHODS
Cell culture, luciferase assay and protein extraction
HEK293 cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum (FBS),
ampicillin/streptomycin and glutamine. Human coronary
artery VSMC cells were purchased from Lonza and early
passage cells were grown in smoothmuscle growthmedium-
2 with 5% FBS and supplements. To induce ER stress
the culture media of subconfluent VSMC was replaced
with serum free media containing 1 M thapsigargin or
Dimethyl sulfoxide (DMSO) as control. At the appropriate
time points the culture media was aspirated and the plates
washed once with phosphate buffered saline (PBS), fol-
lowed by subsequent assay dependent treatments. Expres-
sion constructs were transiently transfected into HEK293
cells using a standard Fugene 6 protocol (Roche). Silencing
GAPDH and negative control silencing RNAs (siRNAs)
were obtained from Ambion. Custom made siRNAs for
TIA-1, including cacaacaaauuggccagua (sense) and uacug-
gccaauuugguugug (antisense), were obtained from Qiagen.
The siRNAs were transfected using Lipofectamine2000
reagent (Invitrogen) according to manufacturer’s instruc-
tions. Cells were harvested 24–72 h after transfection and
firefly luciferase activities were measured using the Dual
Luciferase Assay System (Promega). The luciferase activ-
ity was normalized to the activity of the cotransfected re-
nilla luciferase plasmid. Cytoplasmic protein lysates were
prepared in TX100 lysis buffer as described earlier (10).
Recombinant human GAPDH-protein was obtained from
Abcam.
DNA constructs
Expression construct for TIA-1 was cloned form HeLa cell
library and constructed as described earlier (10). To create a
construct for maltose-binding protein (MBP)-TIA-1 fusion
protein production, TIA-1 cDNAwas inserted into pMAL-
c4x using EcoR1 and HindIII restriction sites and the lig-
ated vector was transformed to OneShot Top10 chemically
competent Escherichia coli cells (Invitrogen). Other con-
structs used in the experiments have been described earlier
(6,9).
RNA probe preparation
cDNA was used as a template for polymerase chain reac-
tion (PCR) reactions whereby T7 RNA polymerase pro-
moter sequence was added to the 5′-end of all fragments
and a 30 bases long poly-A tail was included in the 3′-
oligos for production of polyadenylated RNA probes for
affinity purification. The following 3′-UTR fragments were
produced: 1–847 (full length 3′-UTR), 1–100, 100–300, 1–
600, 300–600 and 600–887. The primer sequences used for
the PCR were described earlier (9). The PCR products
were run on agarose gel and stained with ethidium bro-
mide. The PCR products were excised and purified from
the gel with a PCR purification kit (NucleoSpin,Macherey-
Nagel). RNA transcripts were synthesized from the PCR-
generated templates according to manufacturer’s instruc-
tions (MEGAscript, Ambion).
RNA affinity purification
RNA affinity purification was done as described earlier
(10). Briefly, 2 g of polyadenylated RNA probes were in-
cubated with polystyrene latex beads with dC10T30 oligonu-
cleotides covalently linked to the surface (Oligotex, Qi-
agen). The RNA-coated beads were incubated with cy-
toplasmic extracts in the RNA binding buffer (5 mM
Hepes, pH 7.9, 7.5 mM KCl, 0.5 mM MgCl2, 0.1 mM
ethylenediaminetetraacetic acid (EDTA), 0.5mMdithiotre-
itol (DTT), 0.1 mg/ml yeast tRNA, 0.1 mg/ml bovine
serum albumin, BSA). The beads were then extensively
washed with RNA binding buffer without BSA. Proteins
bound to the RNA probe were resolved on sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and subjected either to western blotting or to coomassie
blue staining according tomanufacturer’s instructions (Bio-
Rad) for mass spectrometry.
Mass spectrometry
Coomassie blue stained protein bands of interest were cut
out the SDS-PAGE gel and the proteins identified by mass
spectrometry as described earlier (6,9,10).
Western blotting
Affinity purified proteins or cell lysates were elec-
trophoresed in SDS-PAGE and transferred into nitro-
cellulose membrane (Hybond ECL). Immunodetection
was performed as described earlier (6). In brief, the mem-
brane was incubated with specific antibodies against the
protein of interest followed by incubation with either fluo-
rescently (Li-Cor and Invitrogen) or biotin labeled (Dako
Cytomation) secondary antibodies. The fluorescently
labeled secondary antibodies were detected with Odyssey
infrared Imaging System (Li-Cor). The biotinylated sec-
ondary antibodies were detected on X-ray film using
streptavidin-HRP conjugate (GE Healthcare) followed by
enhanced chemiluminecence (Amersham ECL Western
Blotting Detection Reagent, GE Healthcare). Primary
antibodies used, were as followed: monoclonal anti--
tubulin (Upstate), monoclonal anti-pEIF2 (Abcam),
polyclonal anti-eIF2 (Abcam), monoclonal anti-GRP78
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(Abcam), monoclonal anti-MBP (New England Biolabs),
monoclonal anti--smooth muscle actin (Sigma Aldrich)
polyclonal anti-GAPDH (Trevigen), polyclonal anti-TIA-1
and monoclonal anti-TIA-1/TIAR (Santa-Cruz) and
polyclonal anti-TIA-1 (BioVision).
Protein immunorecipitation (IP)
The assay was performed essentially as described earlier (9).
In short, TIA-1 was immunoprecipitated fromHEK293 cell
lysates with polyclonal anti-TIA-1 antibody. Pre-immuno
IgG or anti-cyclooxygenase 2 (Cox-2) antibodies were used
as controls. The samples were precleared with protein G-
sepharose beads before adding the anti-TIA-1 or con-
trol antibodies. Protein G-sepharose beads were added to
bind the antibodies followed by extensive washing of the
beads with 100 mM KCl, 5 mM MgCl2, 10 mM HEPES,
pH 7.0, 0.5% NP-40, 1 mM DTT, 100 U/ml RNase in-
hibitor, 2 mM vanadyl ribonucleoside complexes and pro-
tein and phosphatase inhibitor cocktails. Proteins were di-
gested with 0.1% SDS and proteinase K followed by RNA
extraction with phenol-chloroform-isoamyl alcohol mix-
ture. RNA was precipitated with 10 g of yeast tRNA as
carrier. The precipitated RNA was reverse transcribed us-
ing poly-dT oligos followed by PCR with primers targeting
the AT1R coding region.
Production and purification of MBP-TIA-1 proteins
The TIA-1 fusion protein production and purification was
done according to manufacturer’s instructions (New Eng-
land Biolabs). The vector for fusion protein production was
extracted and transformed to E. coli K12 TB1 strain for
protein production. To produceMBP-TIA-1 fusion protein,
the TIA-1-pMAL-c4x transformed E. coli cells were grown
to OD600 of 0.5 and the recombinant protein production
was initiated by 0.3 mM IPTG. After 2 h the cells were har-
vested by centrifugation, resuspended in column buffer (20
mM Tris–HCL, 200 mM NaCl, 1 mM EDTA) and stored
overnight in−20◦C. The cells were thawed and sonicated on
ice before centrifugation. The supernatant was diluted 1:5 in
column buffer and loaded to an amylose resin column. The
column was washed with column buffer 12× the column
volume. The fusion protein was eluted in 3ml fractions with
column buffer containing 10 mMmaltose. After the elution
the protein concentrations of the fractions were measured
with Protein Assay (Bio-Rad) and the protein containing
fractions were pooled. Finally, the proteins were concen-
trated with Amicon Ultra centrifugal filters (Millipore).
Lentiviral silencing of TIA-1 in VSMCs
VSMCs were cultured in 6 well plates (5 × 104 cells/well).
One day after seeding, the cells were transducedwith lentivi-
ral particles packed with pGIPZ shRNA constructs against
TIA-1 or negative controls (Thermo Scientific) at MOI 10,
together with 4 g/ml polybrene in 1 ml of serum free
medium. Four hours post-infection 1 ml of medium with
serumwas added to the cultures, and 24 h post-infection the
medium was replaced with virus-free medium. To kill any
uninfected cells, puromycin was added to the cells (2g/ml)
48 h post-infection. The puromycin selective medium was
replaced daily for 4 days. The cells were grown to confluency
in puromycin-free medium and seeded to 6 cm plates for
qPCR and western blots or 24-well plates for ligand bind-
ing assay.
Real-time PCR (qPCR)
In RNA expression experiments, normal or shRNA si-
lenced VSMCs were grown subconfluent on 6 cm cell cul-
ture plates. Normal VSMCs were exposed to 1 M thap-
sigargin or dimethyl sulfoxide (DMSO) as controls and the
stimulations were stopped at different time points. The total
RNA was isolated from the cultures with NucleospinRNA
II (Macherey-Nagel). A total of 1 g of total RNA from
each sample was used for the first strand cDNA synthe-
sis with SuperScript III reverse transcriptase (Invitrogen).
The cDNA synthesis was carried out according to manu-
facturer’s instructions using oligo-dT primers. qPCR was
performed in LightCycler (Roche) using Maxima SYBR
Green (Fermentas) according to manufacturer’s instruc-
tions. In short, AT1R and  actin (ActB) or  tubulin
(TubB) mRNAs were amplified using specific primers ob-
tained from Invitrogen. ActB was used as a control for nor-
malization in thapsigargin experiments whereas TubB was
used with the shRNA silenced samples. The primers used
in the PCR were as follows: gcaccaggtgtatttgatatag (AT1R
sense), ctgtttccaaatattcccacc (AT1R antisense), gacgacatg-
gagaaaatctg (ActB sense), atgatctgggtcatcttctc (ActB anti-
sense), gtactacaatgaagccacag (TubB sense) and ccagactgac-
caaatacaaag (TubB antisense). The relative concentrations
were calculated from the first 35 cycles against a standard
curve.
Ligand-binding assay
TIA-1-silenced or negative control-transduced VSMCs and
untreated VSMCs were grown to subconfluency on 24-well
plates and either exposed to ER stress by 1 M thapsigar-
gin for various timepoints or left untreated. To study the ex-
pression of AT1Ron cell surface the cultures were subjected
to ligand binding assay as described earlier (12). In short,
the cells were washed twice with PBS containing 0.1% BSA
followed by incubation with 0.2 nM 125I-[Sar1,lle8]Ang II
(PerkinElmer) at +37◦C for 1 h in the absence (total count)
or presence of 1 M Ang II as competitor. The cells were
then washed twice with ice-cold PBS containing 0.1% BSA
and lysed in 0.5 N NaOH. The lysates were mixed with
Optiphase Hisafe 3 (PerkinElmer) and the activity of the
radiolabeled ligand was measured with liquid scintillation
counter (Wallac 1414WinSpectral). AT1R binding was cal-
culated as the difference between the total count and the
count from samples incubated with unlabeled Ang II.
Immunofluorescence staining and RNA-fluorescence insitu
hybridization
Subconfluent VSMC grown on coverslips were exposed to
1 M thapsigargin for 1 h to induce ER stress or to DMSO
as controls. After the stimulation the culture media was
aspirated and the cells were washed once with PBS. The
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cells were fixed with 4% paraformaldehyde in PBS for 15
min at room temperature (RT) followed by two washes
with PBS. After fixation the samples were subjected to ei-
ther immunofluorescence (IF) staining or to RNA fluores-
cence in situ hybridization (FISH). The antibodies used in
the experiments was as follows: monoclonal anti-GAPDH
(Novus Biologicals), polyclonal anti-GAPDH and anti-
TIA-1 (Santa-Cruz), monoclonal anti-PABP1 (Abcam).
For IF, the fixed cells were permeabilized with 0.25% Tri-
ton X-100 (Tx-100) (Bio-Rad) in PBS for 15 min at RT fol-
lowed by three washes with PBS. The samples were blocked
with blocking buffer [5% BSA, 5% normal donkey serum
(NDS), 0.3 M glycine in PBS] for 1 h at RT. Subsequently
the samples were incubated with primary antibodies diluted
in antibody buffer (2.5% BSA, 2.5% NDS, 0.1% Tween-20
in PBS) overnight at +4◦C in a humidified chamber. The
samples were washed quickly with washing buffer [0.1%
Tween-20 in PBS (PBST)] followed by a single 5 min and
two 10 min washes. Next the samples were incubated with
fluorescently labeled secondary antibodies (Alexa Fluor, In-
vitrogen) diluted in the antibody buffer for 1 h at RT fol-
lowed by a series of washes as before with PBST. Finally the
samples were rinsed with PBS and the nuclei were stained
with 4 M Hoechst 33258 (Sigma Aldrich) in PBS. After
rinsing the samples twice with PBS and once with H2O, the
coverslips weremounted tomicroscope slides with ProLong
Gold (Invitrogen) and visualized with Zeiss LSM 780 con-
focal microscope.
For RNA FISH, the cells were permeabilized with 70%
ethanol overnight at +4◦C. After permeabilization the sam-
ples were incubated for 5 min in wash buffer [10% for-
mamide in 2× saline-sodium citrate (SSC)] followed by hy-
bridizationwith fluorescently labeledRNAprobes designed
against AT1R mRNA coding region (Stellaris RNA FISH,
Biosearch technologies). The samples were hybridized with
250 nM probes in hybridization buffer (100 mg/ml dextran
sulfate and 10% formamide in 2× SSC) for 4 h at +37◦C in
a humidified chamber. Following hybridization the samples
were washed twice with washing buffer for 30 min at +37◦C
in a humidified chamber. Next the samples were rinsed once
with PBS and proceeded to blocking and subsequent IF
staining as describes above. The samples were visualized us-
ing Zeiss Axioplan 2 microscope.
Statistical analysis
Data are presented as means ± SD. Statistical analysis was
performed using Student’s paired one-tailed t-test. P< 0.05
were considered significant. Quantification of western blot
band intensities were calculated using the quantification op-
tion of Image Studio version 3.1 imaging software (Li-Cor)
used with the Odyssey Infrared Imaging System for detec-
tion of western blots.
RESULTS
TIA-1 interacts with AT1R mRNA
Our research group has searched for AT1RmRNA-binding
proteins to understand the post-transcriptional mecha-
nisms of AT1R regulation.We assayed the existence of such
RBPs by employing affinity purification using 3′-UTR of
Figure 1. Cytoplasmic association of TIA-1 with AT1R mRNA in
VSMCs. (A) Proteins binding to AT1R 3′-UTRwere affinity purified from
VSMC lysates using an in vitro transcribed AT1R 3′-UTR as bait. A probe
consisting of luciferase coding region was used as the negative control
(NC). At 40 kDa a protein was present in 3′-UTR lane but not in con-
trol lane and this protein (arrow) was then excised, digested and identified
by mass spectrometry. The details of the purification are given under ‘Ma-
terials and Methods’ section. (B) A western blot of proteins isolated by
affinity purification from HEK293 cell lysates was performed and bind-
ing of TIA-1 to AT1R 3′-UTR was confirmed by antibody recognizing
both TIA-1 and TIAR. (C) Binding of endogenous TIA-1 with endoge-
nousAT1RmRNAwas detected by PCRassaywithAT1R specific primers
of reverse transcribed material obtained by IP from cytoplasmic fractions.
Changes in the level of AT1R mRNA associated with TIA-1 were evalu-
ated by measuring its abundance in the IP mixture. Immunoprecipitation
was performed with TIA-1-specific antibody, preimmuno IgG or Cox-2-
specific antibody. PCR products were visualized after electrophoresis in
1% agarose gels stained with ethidium bromide. (D) The colocalization of
TIA-1 andAT1RmRNA in VSMCs was examined by in situ hybridization
using a fluorescently labeled AT1RmRNA-specific probe, followed by im-
munocytochemistry with the anti-TIA-1 antibodies. The distribution of
TIA-1 is shown in green (Figure 1D left panel), AT1R mRNA is shown in
red (Figure 1D middle panel) and the overlap is shown in yellow (Figure
1D right panel). The colocalization of the signals is indicated (arrows). (E)
Mapping of the TIA-1 binding site. Upper panel, a schematic illustration
of AT1R mRNA 3′-UTR probes used for mapping of TIA-1 interaction
sites. Lower panel, western blot detection of TIA-1 from affinity purifica-
tions with probes consisting of various segments of AT1R 3′-UTR from
HEK293 cell lysates.
AT1RmRNA as bait. Previously, we used this technique to
identify p100, GAPDH and HuR as AT1R 3′-UTR bind-
ing proteins (6,9,10). In the present study, a polyadenylated
probe corresponding to nucleotides 1–847 of 3′-UTR was
transcribed and bound to poly-T beads, and then incubated
with cytoplasmic lysates followed by extensive washing. A
band migrating at∼40 kDa was identified (Figure 1A). In a
negative control experiment using fragments of luciferase
coding region, binding was undetectable. Protein was ex-
cised from the gel and digested ‘in gel’ by trypsin. The gen-
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erated peptides were extracted and subjected to mass spec-
trometric analysis. Database (MSDB) search with the com-
bined MALDI-TOF peptide mass fingerprint data identi-
fied (Mascot score 566) the protein as human TIA-1.
To directly test if TIA-1 interacts with AT1R mRNA,
we performed protein separation from HEK293 cell lysates
by RNA affinity purification with full length AT1R 3′-
UTR probe. The samples were immunoblotted for TIA-1
and endogenous TIA-1 was detected (Figure 1B). In this
blot, we utilized antibody recognizing also TIAR (TIA-1
related protein) but no specific TIAR binding to 3′-UTR
was detected. Ribonucleoprotein (RNP) IP was performed
to study the association of TIA-1 with endogenous AT1R
mRNA. The relative enrichment of AT1R mRNA in RNP
IP reaction was tested by reverse transcription, followed
by conventional PCR amplification and then visualized on
agarose gels. RNP IP assays revealed a strong enrichment
of AT1R mRNA with TIA-1 in anti-TIA-1 antibody reac-
tions relative to that of control IP reactions (IgG andCox-2)
(Figure 1C). These results indicate that TIA-1 forms RNP
complex with endogenous AT1R mRNA
To test whether TIA-1 and AT1RmRNA are colocalized
within VSMCs, we performed in situ hybridization using a
fluorescently labeled AT1RmRNA-specific probe, followed
by immunocytochemistry with the anti-TIA-1 antibodies.
These double-staining results (Figure 1D) showa clear colo-
calization of TIA-1 and AT1R mRNA within VSMCs. The
distribution of TIA-1 is shown in green (Figure 1D left
panel), AT1R mRNA is shown in red (Figure 1D middle
panel) and the overlap is shown in yellow (Figure 1D right
panel). These data are consistent with the colocalization of
TIA-1 with AT1R mRNA in the cytoplasm of VSMCs. A
small fraction of TIA-1 colocalized with a P-body marker
GW182 (data not shown).
TIA-1 has two binding sites within AT1R 3′-UTR
Next, we sought to identify the AT1R 3′-UTR regions
involved in interaction with TIA-1. To this end, four
polyadenylated fragments spanning the differentmRNA re-
gions of AT1R 3′-UTR were used in affinity purification.
Probes corresponding to 3′-UTR bases 1–100, 100–300,
300–600 and 600–887 were transcribed and poly-A tail was
included as a part of the primer used in the PCR-reaction.
Schematic representations of the probes are described in
Figure 1E (upper panel). Synthesized mRNAs with poly-
A were bound to poly-T beads, incubated with cytoplas-
mic lysates followed by extensive washing. A western blot
of proteins isolated by RNA affinity purification was per-
formed and TIA-1 expression was detected by polyclonal
anti-TIA-1 antibodies. We mapped the interaction to frag-
ments of 1–100 and 600–887 of 3′-UTR (Figure 1E, lower
panel). These findings indicate that TIA-1 interacts with
two binding sites, one in the proximity of the coding re-
gion and the other in the distal part of the 3′-UTR of AT1R
mRNA.
TIA-1 is a negative regulator of AT1R protein expression
To test the functional consequences of the association be-
tween TIA-1 and AT1R mRNA we used RNA interfer-
ence. Silencing of TIA-1 by transducing coronary artery
VSMCs with TIA-1-directed shRNA effectively lowered
TIA-1 abundance (Figure 2A, upper panel). Depletion of
TIA-1 increased AT1R protein expression as observed by
ligand binding utilizing radiolabeled Ang II to measure
changes in cell surface AT1R expression (Figure 2A, lower
left panel).While increasingAT1Rprotein expression, TIA-
1 silencing decreased the AT1R mRNA expression as mea-
sured by qPCR (Figure 2A, lower right panel). This suggests
that in the absence of stress, endogenousTIA-1 represses the
protein expression of AT1R while having an opposite effect
on the mRNA expression.
To investigate if TIA-1 regulates AT1R mRNA through
region where it binds more extensively, we prepared the het-
erologous reporter construct of luciferase fused with AT1R
3′-UTR. TIA-1 overexpression did not influence luciferase
activity of a construct lacking AT1R 3′-UTR. As shown
in Figure 2B, TIA-1 overexpression in HEK293 cells de-
creased luciferase activity of a vector containing at least one
TIA-1 binding site fused to the 3′-end of a luciferase cod-
ing region. Conversely, TIA-1 silencing in HEK293 cells us-
ing a specific TIA-1-directed siRNA resulted in a signifi-
cant increase in the luciferase activity of a fusion construct
with either 5′ end (1–100) or 3′-end (267–887) TIA-1 bind-
ing sites of the 3′-UTR (Figure 2C). These findings indi-
cate that there are TIA-1-dependent negative regulatory el-
ements within the 3′-UTR of AT1R mRNA. These results
are consistent with the notion that TIA-1 reduces AT1R
protein expression through binding sites within the 3′-UTR.
GAPDH-dependent and -independent binding of TIA1 to
AT1R mRNA
Our prior data with GAPDH showed that TIA-1 and
GAPDH have an overlapping binding site within the 3′-
UTR proximal to the coding region (9). Accordingly, we
postulated that both GAPDH and TIA-1 interact either di-
rectly or through mRNA. To test if the binding of TIA-
1 to AT1R mRNA is influenced by GAPDH, polyadeny-
lated RNAs spanning the 1–100 and 600–887 regions of
AT1R 3′-UTR were synthesized and their interaction with
TIA-1 andGAPDHwas studied after incubating themwith
HEK293 cytoplasmic lysates and affinity purifying the re-
sulting RNP complexes using poly-T-coated beads. West-
ern blot analysis was used to identify TIA-1 and GAPDH
present in the complexes. As shown in Figure 3A (left lanes),
both GAPDH and TIA-1 are present in the complexes. In
GAPDH-depleted HEK293 lysates, TIA-1 was no longer
present in the 1–100 RNP complexes whereas in the com-
plexes containing the 600–887-region the binding of TIA-
1 was unaffected by GAPDH-depletion. In contrast, de-
pletion of TIA-1 did not have an effect on GAPDH bind-
ing to the 1–100 region whereas with the 600–887-region
there was no binding of GAPDH to the RNA in any of the
samples. These results suggest that GAPDH is required for
TIA-1 binding to mRNA at the 1–100 region of AT1R 3′-
UTR. We confirmed this data with purified GAPDH pro-
tein and recombinant MBP-TIA-1 fusion protein. In this
affinity purification experiment MBP-TIA-1 and GAPDH
were added separately and together to AT1R 3′-UTR. TIA-
1 binding to 1–100 of AT1R 3′-UTR significantly increased
if GAPDH was present, whereas at the distal site (600–
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Figure 2. TIA-1 negatively regulates AT1R protein expression via mRNA
3′-UTR. (A) The effect of TIA-1 silencing on endogenous AT1R protein
and mRNA expression. VSMC were transduced with a lentiviral shRNA
construct against TIA-1 (shTIA-1) or with a non-silencing control (shC-
TRL). The western blot at the top show successful TIA-1 silencing and
-smooth muscle actin (-SMA) expression to confirm the VSMC pheno-
type of the cells after virus infection. -tubulin was used as a loading con-
trol. The bottom left panel shows AT1R protein expression as quantified
by ligand binding using radiolabeled Ang II to measure changes in the cell
surface receptor expression. The bottom right panel show AT1R mRNA
expression as quantified by qPCR. The results are shown as relative quan-
tity to shCTRL AT1R mRNA expression and the results are normalized
to -tubulin expression. Results represent the mean ± SD of an average of
three independent experiments. P < 0.05 versus the shCTRL. (B) TIA-1
effect on AT1R 3′-UTR-mediated reporter gene expression. Upper panel,
a schematic illustration of luciferase constructs with AT1R 3′-UTR frag-
ments used in the experiment. Lower panel, HEK293 cells were cotrans-
fected with the various luciferase-3′-UTR constructs together with renilla
luciferase and either empty vector (CTRL) or with TIA-1 expression plas-
mid.A construct with inverted luciferase coding region as 3′ UTRwas used
as negative control (NC). Cells were lysed and assayed for firefly and renilla
luciferase activities. Results represent themean± SDof an average of three
independent experiments. *P < 0.05 versus samples transfected with the
empty expression vector. Western blots showing the luciferase expression
and -tubulin as loading control are shown below. The anti-TIA-1 west-
ern blots showing the overexpression of TIA-1 and -tubulin expression as
loading control are shown on the right. (C) Effect on reporter gene expres-
sion following TIA-1 silencing. HEK293 cells were transfected with the
same luciferase constructs as in Figure 2B together with a non-silencing
control (siCTRL) or with siTIA-1 expression construct and assayed for
firefly and renilla luciferase activities in similar manner. Results represent
the mean ± SD of an average of three independent experiments. *P< 0.05
versus samples transfected with the siCTRL. Western blots showing the
luciferase expression and -tubulin as loading control are shown below.
The western blots showing TIA-1 silencing and a -tubulin control blot
are shown on the right.
Figure 3. GAPDH-dependent and -independent binding of TIA-1 to
AT1R mRNA. (A) GAPDH-dependent TIA-1 binding at the 1–100 bind-
ing site. Left panel, affinity purification with the 1–100 and 600–887
fragments of AT1R 3′-UTR were performed from siCTRL-, siTIA-1- or
siGAPDH-transfected HEK293 cells as indicated. The upper lane shows
TIA-1 detection by western blot from the affinity purified samples from
the 1–100 binding site and the second lane from the 600–887 binding site.
The third lane show TIA-1 expression in whole cell lysates and the bottom
lane -tubulin expression, used as a loading control. Right panel, same ex-
perimental setup was used as in the left panel but the samples were probed
for GAPDH. (B) Validation of direct TIA-1 and GAPDH interaction on
AT1R 3′-UTR. Affinity purification was performed with 1–100 or 600–
887 fragments of AT1R 3′-UTR from samples containing purified recom-
binant MBP-TIA-1, GAPDH or both, as indicated (left panel). Binding
of TIA-1 and GAPDH to the probes were visualized by western blotting
(upper left panel). The band-intensities from the western blot were quan-
tified (lower left panel). Results represent the mean ± SD of an average
of three independent experiments. *P < 0.05 versus the result from 1–100
region with only TIA-1 added. A western blot of purified MBP-TIA-1 de-
tected by anti-TIA-1 antibody is shown in the upper right panel. To con-
firm that the binding ofMBP-TIA-1 toRNA ismediated by TIA-1 and not
MBP the full length AT1R 3′-UTR was used in affinity purification con-
taining recombinant GAPDH and either MBP-TIA-1 or MBP only. The
binding of the proteins to the probe were visualized by western blotting
(lower right panel). The upper arrow indicate the location of MBP-TIA-
1-fusion protein and the lower arrow the location of MBP. (C) Effect of
TIA-1 and GAPDH on the expression of a reporter gene with mutated
GAPDH binding site. HEK293 cells were transfected with a luciferase ex-
pression construct fused with 1–100 fragment of AT1R 3′-UTR or with a
fragment lacking the GAPDH binding motif (del 9/11). The cells were co-
transfected with TIA-1 or GAPDH expression vectors or with an empty
control vector (CTRL). Following transfections, the cells were lysed and
the luciferase activities measured (Left panel). Results represent the mean
± SD of an average of three independent experiments. *P < 0.05 versus
samples transfected with the empty expression vector. Western blots show-
ing the luciferase expression and -tubulin as loading control are shown
below. Binding of TIA-1 and GAPDH to the wild-type (1–100) and mu-
tated (del 9/11) RNA was studied by affinity purification from HEK293
lysates. The affinity purified proteins visualized by western blot are shown
in the right panel.
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887) TIA-1 binding was not dependent onGAPDH (Figure
3B, upper left panel). When GAPDH was present, quan-
tification of the western blot band intensities showed an
∼1.5-fold binding of TIA-1 to the 1–100-region relative
to samples containing TIA-1 alone. At the distal 600–887-
region there was no statistically significant change (Figure
3B, lower left panel). To confirm that the mRNA binding of
MBP-TIA-1-fusion protein was mediated by TIA-1, affin-
ity purification with AT1R 3′-UTR was performed in sam-
ples containing GAPDH and either MBP-TIA-1 or MBP.
Western blot analysis of the samples showed that while
MBP-TIA-1 bound to the RNA, MBP alone did not (Fig-
ure 3B, lower right panel). To examine the possibility that
TIA-1 and GAPDH would interact directly, we tried co-
immunoprecipitation under various conditions. We could
not demonstrate co-immunoprecipitation of GAPDH and
TIA-1 in mRNA-depleted environment neither with puri-
fied proteins norwithHEK293 cell lysates (data not shown).
Nor did strong overexpression of GAPDH and TIA-1 in
the HEK293 lysates improve the yield of immunoprecipita-
tion (data not shown). This data indicates that TIA-1 and
GAPDH form complexes with AT1R mRNA but the two
proteins do not interact directly.
GAPDH-dependent TIA-1 binding site
To seek further evidence for GAPDH-dependent TIA-1
binding to mRNA, we used an altered version of a chimeric
construct in which luciferase was fused with a mutated 1–
100 of AT1R 3′-UTR that does not bind to GAPDH nor
respond to GAPDH silencing or overexpression (9). Ini-
tially, this construct unresponsive to GAPDH was identi-
fied in random, saturating mutagenesis designed to iden-
tify critical binding site for GAPDH-RNA interaction. In-
active 1–100 of AT1R 3′-UTR had bases at sites 9 and 11
removed (del 9/11). We hypothesized that TIA-1 does not
affect the luciferase activity when a necessary mediator pro-
tein, GAPDH, is unable to link TIA-1 to AT1R 3′-UTR. To
test this, HEK293 cells were transfected with a luciferase ex-
pression construct fused with either the 1–100 fragment of
AT1R 3′-UTR or with 3′-UTR lacking functional GAPDH
binding motif (del 9/11). The cells were cotransfected with
either TIA-1 or GAPDH expression constructs or with an
empty vector as control. Following the transfections the
cells were lysed and the luciferase activity measured. Both
TIA-1 and GAPDH overexpression led to a decreased lu-
ciferase activity of the wild-type construct (Figure 3C, left
panel). In line with our expectations, the construct lacking
the binding site for GAPDH (del 9/11) did not respond
to neither GAPDH nor TIA-1 overexpression. Binding of
TIA-1 and GAPDH to the 1–100 and mutated (del 9/11)
fragment of AT1R 3′-UTR was studied by affinity purifica-
tion from HEK193 lysates followed by western blot detec-
tion. Both TIA-1 and GAPDH bound to the 1–100 frag-
ment whereas almost no binding of TIA-1 was observed
with the del 9/11 fragment lacking the GAPDH binding
site (Figure 3C, right panel). Taken together, our data ar-
gues for the proximal binding site within AT1R 3′-UTR to
require GAPDH for both binding and function.
Figure 4. AT1R mRNA dissociates from TIA-1 in response to ER stress.
VSMCs were exposed to vehicle (A–C) or 1 M thapsigargin for 1 h (D–
F). After stimulations the cells were fixed and immunofluorescently stained
against TIA-1 and PABP1 (A and D). Alternatively the cells were in situ
hybridized with a fluorescently labeled RNA probe against AT1R mRNA
and immunofluorescently stained against PABP1 (B and E) or TIA-1 (C
and F). The subcellular localization of themRNAand proteins (FISH/IF)
was visualized with a fluorescence microscope whereas colocalization of
the proteins (IF) was visualized with a confocal laser scanning microscope.
Colocalization of the signals are indicated (arrows). The nuclear localiza-
tion of TIA-1 is visible in the IF stainings (A and D) as the cells are per-
meabilized with 0.25% TX-100. In the FISH combined with IF stainings
against TIA-1 (C and F) the nuclear localization of TIA-1 is not shown as
the cells are permeabilized with 70% ethanol leaving the nuclear proteins
undetected by the antibodies. The details of the staining procedures are
given under ‘Materials and Methods’ section.
Interaction of AT1R mRNA and TIA-1 in stressed cells
To explore the interaction of TIA-1 with AT1R mRNA
in stressed cells, we exposed coronary artery VSMC to
thapsigargin, an ER stressor that induces the formation of
SG. VSMCs were fixed, permeabilized and blocked before
staining for TIA-1 and another well-established SGmarker,
poly-A binding protein 1 (PABP1) (11,13). In the unstressed
cells TIA-1was primarily nuclear, showing only a diffuse cy-
toplasmic expression (Figure 4A), whereas in thapsigargin-
treated VSMCs TIA-1 accumulated at multiple cytoplas-
mic foci, which represented SGs (Figure 4D). The nuclear
localization of TIA-1 is detectable in Figure 4A and D as
the nuclear envelope is permeabilized by the 0.25% TX-100
used for the immunofluorescent staining. Colocalization of
PABP1 confirms that TIA-1 is accumulated in SGs. The lo-
calization of AT1R mRNA in stressed cells was studied in
FISH experiment using a probe against the coding region
of AT1R mRNA and immunostaining of the SG marker
PABP1 or TIA-1. Superposition of FISH of AT1R mRNA
combined with immunostaining of PABP1 show that no
AT1R mRNA accumulation to SGs occurred during ER
stress (Figure 4B and E). Superposition with TIA-1 im-
munostaining, in turn, shows that in unstressed coronary
artery VSMCs TIA-1 and AT1R mRNA colocalize but in
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stressed cells they do not (Figure 4C and F). These observa-
tions suggest that the distribution of AT1RmRNA is unaf-
fected by ER stress. AT1R mRNA and TIA-1 colocalize in
unstressed conditions, but when cells are stressed TIA-1 is
recruited to SGswhile AT1RmRNA is not. Thus, ER stress
releases TIA-1 from AT1R mRNA. The FISH experiments
do not show the nuclear TIA-1 in Figure 4C and F as the
cells are permebilized with 70% ethanol leaving the nuclear
proteins undetected by the antibodies.
ER stress increases endogenous AT1RmRNAand protein ex-
pression
So far, we have shown that in unstressed cells cytoplasmic
TIA-1 binds toAT1RmRNAand suppressesAT1Rprotein
expression. However, the major biological function of TIA-
1 is related to ER stress where it sequesters mRNAs in SGs.
Prior reports suggest that ER stress increases AT1R protein
expression (6,9,14–16). To directly test whether ER stress
upregulates AT1R protein expression, we treated coronary
artery VSMCswith a well-knownER stress-inducing agent,
thapsigargin and measured mRNA and ligand binding of
AT1R. RNAwas purified from thapsigargin stimulated and
unstimulated VSMCs, reverse-transcribed, quantified by
qPCR and normalized against  actin mRNA. ER stress-
induced SG assembly is initiated by phosphorylation of
eIF2 which inhibits the formation of functional preiniti-
ation complexes (11,17). Successful induction of ER stress
by thapsigargin was thus monitored by western blotting,
showing an increase in both eIF2 phosphorylation andER
chaperone GRP78 (Figure 5A, right panel). In thapsigargin
treated cells the AT1R mRNA levels were ∼2-fold relative
to untreated cells normalized against the  actin expression
(Figure 5A, left panel). Similarly, AT1R ligand binding us-
ing radiolabeled Ang II to detect the cell surface expressed
AT1R shows that thapsigargin increased the protein expres-
sion of AT1R (Figure 5B, left panel). To test whether TIA-
1 silencing has an effect on ER stress-induced increase in
AT1R mRNA-levels as seen in Figure 5A, the control and
TIA-1-silenced VSMCs were exposed to thapsigargin and
the change in AT1R mRNA expression was quantified by
qPCR. Under unstressed conditions there was a significant
decrease inAT1RmRNA levels in TIA-1 silenced cells com-
pared to the controls, consistent with the results seen in Fig-
ure 2A. In the thapsigargin treated cells, however, there was
no statistically significant difference in the AT1R mRNA
levels between the control and TIA-1-silenced cells (Figure
5B, right panel). These results are consistent with earlier ob-
servations that AT1R escapes the stress-induced transcrip-
tional silencing (6,9,14–16). Further, the thapsigargin effect
was dependent on TIA-1 as TIA-1 silenced VSMCs had in-
creased baseline AT1R protein expression but no longer re-
sponded to the thapsigargin treatment.
GAPDH interaction with AT1R mRNA 3′-UTR is not regu-
lated by ER stress
TIA-1 interaction with the proximal 3′-UTR binding site in
AT1R mRNA is GAPDH-dependent. To know if GAPDH
has a role in ER stress response, we hybridized fluorescently
labeled RNA probe with AT1R mRNA in VSMCs and fol-
lowed GAPDH localization by immunofluorescence. The
Figure 5. ER stress increases AT1R mRNA and protein expression. (A)
ER stress effect on AT1R mRNA expression. VSMCs were treated with 1
M thapsigargin and at the indicated time points the cells were harvested
and the total RNAwas extracted. One microgram of total RNA from each
time point was reverse transcribed to cDNA using oligo-dT primers. The
cDNAs were analyzed by qPCR using gene specific primers for AT1R and
 actin. The results are normalized against the  actin values and represent
the mean± SD values relative to untreated samples from same time points
of an average of three independent experiments. *P < 0.05 versus the re-
sults at 0 h. As shown on right, the induction of ER stress was confirmed
by visualizing the increase of phosphorylated eIF2 (p-eIF2) by western
blot using a specific antibody against serine 51 phosphorylated eIF2 (up-
per lane). The expression of total eIF2  is shown in the second lane. As
another indicator of ER stress induction, the increased expression of the
ER chaperone GRP78 is shown in the third lane.  tubulin was used as a
loading control. (B) Effect of ER stress and TIA-1 on endogenous AT1R
expression. The same TIA-1 and control silenced VSMCs as in Figure 2A
were subjected to thapsigargin-induced ER stress. At the indicated time
points endogenous AT1R expression was measured by ligand binding us-
ing radiolabeled Ang II to measure changes in the cell surface receptor
expression (left panel). Results represent the mean ± SD of an average of
three independent experiments. *P < 0.05 versus the shCTRL at 0 h. To
study if TIA-1 silencing has an effect on ER stress induced upregulation of
AT1R mRNA expression as seen in Figure 5A, the TIA-1 and control si-
lenced VSMCs were subjected to 1 M thapsigargin for 1 h and the AT1R
mRNA expression was quantified by qPCR as in Figure 5A (right panel).
The results are normalized against the control silenced samples (shCTRL)
and represent the mean ± SD of an average of three independent experi-
ments. *P < 0.05 versus the shCTRL.
colocalization of GAPDH with AT1R mRNA remained
unaltered by ER stress (Figure 6A and D). This occurred
despite the fact that in thapsigargin-stressed cells, GAPDH
colocalized with both PABP1 (Figure 6B and E) and TIA-1
(Figure 6C and F) in SGs. This result identified GAPDH
as a novel component of SGs. The abundant GAPDH ap-
pears to have different pools of protein. One pool is taken to
SGs by ER stress whereas the other pool is bound to AT1R
mRNA.
DISCUSSION
Our earlier studies have systematically analyzed the mech-
anisms of post-transcriptional regulation of AT1R. Since
post-transcriptional regulation is governed by the forma-
tion of RNP complexes, we sought to identify RNPs that
bind to AT1R mRNA. The binding of TIA-1 to AT1R
mRNA in unstressed cells or cell lysates was supported by
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Figure 6. GAPDH binding to AT1R mRNA is unaffected by ER stress.
VSMCs were exposed to vehicle (A–C) or 1 M thapsigargin for 1 h (D–
F). After stimulations the cells were fixed and in situ hybridized with a flu-
orescently labeled RNA probe against AT1R mRNA and immunofluores-
cently stained against GAPDH (A and D). Alternatively the cells were im-
munofluorescently dual labeled against GAPDH and PABP1 (B and E) or
TIA-1 (C and F). The subcellular localization of the mRNA and proteins
(FISH/IF) was visualized with a fluorescent microscope whereas the colo-
calization of the proteins (IF) was visualized with a confocal laser scanning
microscope. Colocalization of the signals is indicated (arrows). The details
of the staining procedures are given under ‘Materials and Methods’ sec-
tion.
affinity purification of TIA-1 with AT1R 3′-UTR and colo-
calization of TIA-1 and AT1R mRNA by immunofluores-
cence microscopy as well as immunoprecipitation of AT1R
mRNA from TIA-1 lysates. In affinity purification of cell
lysates with different fragments of AT1R 3′-UTR, TIA-1
was found to have two binding sites. TIA-1 and GAPDH
cooperate in binding to the binding site proximal to cod-
ing region, whereas TIA-1 binding to the distal binding site
appears to be direct as shown by in vitro binding of puri-
fied GAPDH with MBP-TIA-1. In unstressed cells, TIA-
1 associated with AT1R mRNA and decreased the protein
expression of the receptor. The better-known function for
TIA-1 is its role in the ER stress-induced translational si-
lencing. SG assembly is regulated by one or more RBPs in-
cluding TIA-1 (11,13). Interestingly, ER stress induces the
dissociation of TIA-1 from AT1R mRNA. TIA-1 goes into
the newly formed SGs whereas AT1R mRNA remains in
the cytoplasm escaping the ER stress-induced translational
suppression.
Angiotensin II and its most important receptor AT1R
are part of system responsible for the adaptation of car-
diovascular system to new hemodynamic environments
(1). Hemodynamic and structural changes due to various
stresses such as hypertension, atherosclerosis or myocardial
infarction are partly mediated by AT1R (8,18–22). AT1R is
upregulated by different oxidative and ER stress-inducing
factors (6,9,14,15). Oxidative stress is associatedwith awide
variety of pathophysiologic events such as inflammation
in atherosclerosis. Exposure to nonlethal level of oxida-
tive stress leads to dissociation of GAPDH from AT1R 3′-
UTR that results in a loss of GAPDH-mediated transla-
tional suppression and increase in AT1R expression both
in kidney and vascular cells (9). ER stress is activated by
stress-sensing serine/threonine kinases that phosphorylate
eIF2 resulting in translational stalling and recruitment of
e.g. TIA-1 to initiate the assembly of SGs (23).
Oxidative and ER stress are closely linked (24,25). For
example, accumulation of ROS induces ER stress and un-
folded protein response (UPR) by disrupting the ER Ca2+
homeostasis. Accumulation of cytoplasmic Ca2+ increases
mitochondrial ROS production (26).We have previously re-
ported GAPDH to bind the 3′ UTR of AT1R mRNA and
to suppress its translation (9). This regulation was shown to
be ROS dependent as H2O2 dissociated GAPDH from the
AT1R mRNA, leading to increased AT1R protein expres-
sion.
During cellular stress, mRNAs are directed to SGs where
they remain translationally inactive until the stress has been
relieved and the mRNAs can be restored to the transla-
tional machinery (27). However, some mRNAs escape SGs
and are translated despite ER stress (28,29). TIA-1 is part
of stress-regulatory machinery that reprograms translation
from a normal state to a stress state in order to focus its
limited translational capacity to selectively express stress
response genes. Although TIA-1 is predominantly in the
nucleus, cytoplasmic TIA-1 binds to AT1R mRNA in un-
stressed cells. Triggering of the ER stress response by thap-
sigargin leads to TIA-1 translocation into SGs and loss
of colocalization with AT1R mRNA. ER stress dissociates
TIA-1 from AT1R 3′-UTR, TIA-1-mediated suppression is
relieved and AT1R mRNA avoids transportation to SGs.
We found that GAPDH is required for TIA-1 binding
to AT1R 3′-UTR. This is supported by affinity purification
data in which silencing of GAPDH decreased the presence
of TIA-1 inRNP complexes pulled downby 1–100 fragment
of AT1R 3′-UTR. Secondly, partial deletion of GAPDH
binding site within 1–100 of AT1R 3′-UTR blocks the bind-
ing of GAPDH as well as TIA-1. SGs comprise a number
of RBPs including regulators of mRNA stability and trans-
lation such as TTP, TIA-1 and CPEB (11,30,31). We found
GAPDH to be a novel SG protein that is translocated into
SGs by ER stress. In contrast to TIA-1, GAPDH remains
bound to AT1R mRNA while a separate pool of GAPDH
is translocated to SGs by ER stress.
In summary, the ER stress-dependent association of
TIA-1 with AT1R mRNA was validated using several ap-
proaches. In unstressed cells, TIA-1 decreasesAT1Rprotein
expression. In stressed cells, TIA-1 dissociates from AT1R
mRNA and is targeted to SGs. AT1R protein expression
is increased as AT1R mRNA avoids the ER stress-induced
translational suppression and as TIA-1-mediated suppres-
sion is released. These discoveries provide comprehensive
and valuable insight into the RNP complexes that govern
AT1R expression at the post-transcriptional level.
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